EVOCA is a precision biocontrol solution with a new mode of action, recognized by the Fungicide Resistance Action Committee (FRAC), that targets the fungal pathogens botrytis (grey mold) and powdery mildew in high-value fruits and vegetables while minimizing the risk to beneficial organisms or the environment.

With EPA’s approval, Biotalys will proceed with the dossiers for state registrations in California and Florida.

In Europe, EVOCA has entered the peer review phase. The Netherlands has proposed its approval in Europe, subject to the submission of certain additional data as requested during the peer review phase.

Additionally, the company can move forward with building up the U.S. regulatory submission for EVOCA NG, a next-generation product that is currently in the final phases of development. The regulatory review process for EVOCA NG is expected to be significantly shorter than for EVOCA, as the product contains the same active ingredient and features enhanced formulation and production methods. Biotalys hopes to secure registration of EVOCA NG in the U.S. by 2029 and in the EU and Brazil by 2030.

Biotalys positions EVOCA as a novel, sustainable solution for growers to protect their crops, with the flexibility for use in both pre- and post-harvest applications across a wide range of food crops in both greenhouse and outdoor growing conditions. The company also highlights its compatibility with an array of application methods and easy integration into existing farm management practices. Additionally, the new mode of action may help manage resistance buildup when compared with existing fungicides.

EPA’s documents regarding EVOCA can be read here.